Without intervention, many patients with RP face the risk of legal blindness ... treated eyes achieved a statistically significant two-line gain (10 letters) in low-luminance visual acuity ...

Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a fully integrated, late-stage biotechnology company advancing a sustainable pipeline of genetic therapies for rare disorders with high unmet need, today ...